Literature DB >> 26110118

What is schizophrenia? 25 years of research into schizophrenia - the Age Beginning Course Study.

Heinz Häfner1.   

Abstract

We studied a population-based sample of 232 first-onset cases of schizophrenia aged 12 to 59 years at first admission retrospectively back to illness onset and prospectively up to 11.2 years later. We compared them with psychiatrically healthy age- and sex-matched population controls and equally matched first-admission patients diagnosed with major depression. At schizophrenia onset women are several years older than men. The social factors tested did not explain the finding. Women's higher level of social development at onset is associated with a better medium-term functional and social outcome. Prodromal schizophrenia and depression are equal in length and diagnostically distinguishable only after the onset of positive symptoms. The sex difference in age at onset, invariable across cultures and ethnicities, is explained by a protective effect of oestrogen, which down-regulates D2 receptors. A higher genetic load antagonizes this effect. Long-term symptom-related illness course exhibits a plateau after three years, the positive symptom dimension after two years, the depressive and the negative dimensions do so after three to five years. The most prevalent symptom is depressive mood. Male first episodes are more frequent and more severe in the first half of life, female ones in the second half. Aetiological conclusions will be drawn.

Entities:  

Keywords:  Age; Schizophrenia and depression; Sex; Symptom dimensions; Types of illness course

Year:  2015        PMID: 26110118      PMCID: PMC4473488          DOI: 10.5498/wjp.v5.i2.167

Source DB:  PubMed          Journal:  World J Psychiatry        ISSN: 2220-3206


  4 in total

Review 1.  Gender differences in age at onset of schizophrenia. An overview.

Authors:  M C Angermeyer; L Kühn
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

2.  The ABC Schizophrenia Study: a preliminary overview of the results.

Authors:  H Häfner; K Maurer; W Löffler; W an der Heiden; P Munk-Jørgensen; M Hambrecht; A Riecher-Rössler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-08       Impact factor: 4.328

3.  ABC Schizophrenia study: an overview of results since 1996.

Authors:  H Häfner; K Maurer; W an der Heiden
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-05       Impact factor: 4.328

Review 4.  A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology.

Authors:  John McGrath; Sukanta Saha; Joy Welham; Ossama El Saadi; Clare MacCauley; David Chant
Journal:  BMC Med       Date:  2004-04-28       Impact factor: 8.775

  4 in total
  1 in total

1.  The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-31       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.